English

NUTRALIFE BIOSCIENCES, INC

EDGAR

Quarterly report (10-Q) · filed 2022-11-21

49 filing records in this dataset, filed from 2013-09-26 to 2022-11-21. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

115 thousand USD

2022 Q3 · USD

Exact inputs and evidence

Revenue: 115149 USD Source

Operating margin

-386.68%

2022 Q3 · %

Exact inputs and evidence

Operating Income: -445260 USD Source
Revenue: 115149 USD Source

Operating cash flow

-440 thousand USD

2022 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1141333 USD Source
Operating Cash Flow: -701373 USD Source

Cash and cash equivalents: 432 thousand USD 2022-09-30 Source
Exact value

431713 USD
Long-term debt including current maturities: 243 thousand USD 2021-09-30 Source
Exact value

243275 USD
Shares outstanding: 177 million shares 2022-09-30 Source
Exact value

176623223 shares

Reported share-count change

5.00% · 8.41 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

168215501 shares · 2021-09-30· Source
176623223 shares · 2022-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

632 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Revenue: 626619 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 246124 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 80478 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 55835 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 115149 USD · 2022-07-01 – 2022-09-30 Source

Operating cash flow

-669 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -487000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -959286 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -453000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -701373 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -453000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -1141333 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -701373 USD · 2022-01-01 – 2022-06-30 Source

Capital expenditure

1.46 million USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Capital expenditure: 729507 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 1044695 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 729507 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 1457903 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 1044695 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 1464494 USD · 2019-01-01 – 2019-12-31 Source
Capital expenditure: 1457903 USD · 2019-01-01 – 2019-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-11-21.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2021-12-31
Operating income: 7 of 11 periods available· newest 2021-12-31
Net income: 9 of 11 periods available· newest 2021-12-31
Operating cash flow: 9 of 11 periods available· newest 2021-12-31
Capital expenditure: 2 of 11 periods available· newest 2019-12-31
Total assets: 9 of 11 periods available· newest 2021-12-31
Total liabilities: 6 of 11 periods available· newest 2021-12-31
Current assets: 9 of 11 periods available· newest 2021-12-31
Current liabilities: 9 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2020-12-31
Shares outstanding: 9 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-50.1%

Prior period

USD 1.26 million

2020-01-01 – 2020-12-31
Current period

USD 626,619

2021-01-01 – 2021-12-31

Exact inputs and evidence

626619 − 1255784 = -629165 USD

1255784 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
626619 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NUTRALIFE BIOSCIENCES, INC · 2021-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Year-over-year change in Revenue: -629165 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 626619 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#726455 Filing: 000149315222009623 Input fundies:Revenue: 1255784 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#726838 Filing: 000149315222009623
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 2.94 million

Prior period

−USD 2.89 million

2020-01-01 – 2020-12-31
Current period

−USD 5.83 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-5827507 − -2889940 = -2937567 USD

-2889940 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-5827507 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NUTRALIFE BIOSCIENCES, INC · 2021-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Year-over-year change in Net income: -2937567 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -5827507 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#917120 Filing: 000149315222009623 Input fundies:NetIncome: -2889940 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#917482 Filing: 000149315222009623
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 797,240

Prior period

−USD 1.28 million

2020-01-01 – 2020-12-31
Current period

−USD 487,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

-487000 − -1284240 = 797240 USD

-1284240 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-487000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NUTRALIFE BIOSCIENCES, INC · 2021-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Year-over-year change in Operating cash flow: 797240 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -487000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#1030750 Filing: 000149315222009623 Input fundies:OperatingCashFlow: -1284240 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#936517 Filing: 000149315222009623
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 626,619 100% of revenue
Cost of revenue USD 543,031 87% of revenue
Operating expenses USD 4.56 million 727% of revenue
Operating income −USD 4.47 million −714% of revenue
Tax, interest and other Derived USD 1.35 million 216% of revenue
Net income −USD 5.83 million −930% of revenue

Cash

Operating cash flow −USD 487,000 −78% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Operating loss: operating costs were 3,433% of revenue.
2016 Operating loss: operating costs were 1,032% of revenue.
2017 Operating loss: operating costs were 1,420% of revenue.
2018 Operating loss: operating costs were 151% of revenue.
2019 Operating loss: operating costs were 259% of revenue.
2020 Operating loss: operating costs were 257% of revenue.
2021 Operating loss: operating costs were 814% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2012-01-01 – 2012-12-31	126576	Unavailable	Unavailable	Unavailable	-387748	Unavailable	Source 2012-01-01 – 2012-12-31: 126576 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -387748 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -290983 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	479328	Unavailable	Unavailable	Unavailable	-2083359	Unavailable	Source 2013-01-01 – 2013-12-31: 479328 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -2083359 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -902486 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	62274	2137994 Derived	-2075720	0 Derived	-2075720	Unavailable	Source 2014-01-01 – 2014-12-31: 62274 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -2075720 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -2075720 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -1231077 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	225293	2324064 Derived	-2098771	0 Derived	-2098771	Unavailable	Source 2016-01-01 – 2016-12-31: 225293 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -2098771 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -2098771 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -726705 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	1790168	25419285 Derived	-23629117	0 Derived	-23629117	Unavailable	Source 2017-01-01 – 2017-12-31: 1790168 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -23629117 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -23629117 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -1018070 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	3711327	5617371 Derived	-1906044	168493 Derived	-2074537	-816305 Derived	Source 2018-01-01 – 2018-12-31: 3711327 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -1906044 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -2074537 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -234673 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 581632 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	2133624	5528998 Derived	-3395374	612029 Derived	-4007403	-4398935 Derived	Source 2019-01-01 – 2019-12-31: 2133624 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -3395374 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -4007403 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -2934441 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1464494 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1255784	3228836 Derived	-1973052	916888 Derived	-2889940	Unavailable	Source 2020-01-01 – 2020-12-31: 1255784 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -1973052 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -2889940 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -1284240 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	626619	5099263 Derived	-4472644	1354863 Derived	-5827507	Unavailable	Source 2021-01-01 – 2021-12-31: 626619 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -4472644 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -5827507 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -487000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 626.6K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Revenue	126576	Revenue: 126576 Open source
20132013-12-31	Revenue	479328	Revenue: 479328 Open source
20142014-12-31	Revenue	62274	Revenue: 62274 Open source
20162016-12-31	Revenue	225293	Revenue: 225293 Open source
20172017-12-31	Revenue	1790168	Revenue: 1790168 Open source
20182018-12-31	Revenue	3711327	Revenue: 3711327 Open source
20192019-12-31	Revenue	2133624	Revenue: 2133624 Open source
20202020-12-31	Revenue	1255784	Revenue: 1255784 Open source
20212021-12-31	Revenue	626619	Revenue: 626619 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-50.1% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Year over year	No prior comparable period	Revenue: 126576 Open source
20132013-12-31	Year over year	278.7%	Revenue: 479328 Open source Revenue: 126576 Open source
20142014-12-31	Year over year	-87%	Revenue: 62274 Open source Revenue: 479328 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 225293 Open source
20172017-12-31	Year over year	694.6%	Revenue: 1790168 Open source Revenue: 225293 Open source
20182018-12-31	Year over year	107.3%	Revenue: 3711327 Open source Revenue: 1790168 Open source
20192019-12-31	Year over year	-42.5%	Revenue: 2133624 Open source Revenue: 3711327 Open source
20202020-12-31	Year over year	-41.1%	Revenue: 1255784 Open source Revenue: 2133624 Open source
20212021-12-31	Year over year	-50.1%	Revenue: 626619 Open source Revenue: 1255784 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -713.8% 2021

Net margin -930% 2021

Free cash flow margin -206.2% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Operating margin	Not reported	Revenue: 126576 Open source
2013-12-31	Operating margin	Not reported	Revenue: 479328 Open source
20142014-12-31	Operating margin	-3,333.2%	Operating Income: -2075720 Open source Revenue: 62274 Open source
20162016-12-31	Operating margin	-931.6%	Operating Income: -2098771 Open source Revenue: 225293 Open source
20172017-12-31	Operating margin	-1,319.9%	Operating Income: -23629117 Open source Revenue: 1790168 Open source
20182018-12-31	Operating margin	-51.4%	Operating Income: -1906044 Open source Revenue: 3711327 Open source
20192019-12-31	Operating margin	-159.1%	Operating Income: -3395374 Open source Revenue: 2133624 Open source
20202020-12-31	Operating margin	-157.1%	Operating Income: -1973052 Open source Revenue: 1255784 Open source
20212021-12-31	Operating margin	-713.8%	Operating Income: -4472644 Open source Revenue: 626619 Open source
20122012-12-31	Net margin	-306.3%	Net Income: -387748 Open source Revenue: 126576 Open source
20132013-12-31	Net margin	-434.6%	Net Income: -2083359 Open source Revenue: 479328 Open source
20142014-12-31	Net margin	-3,333.2%	Net Income: -2075720 Open source Revenue: 62274 Open source
20162016-12-31	Net margin	-931.6%	Net Income: -2098771 Open source Revenue: 225293 Open source
20172017-12-31	Net margin	-1,319.9%	Net Income: -23629117 Open source Revenue: 1790168 Open source
20182018-12-31	Net margin	-55.9%	Net Income: -2074537 Open source Revenue: 3711327 Open source
20192019-12-31	Net margin	-187.8%	Net Income: -4007403 Open source Revenue: 2133624 Open source
20202020-12-31	Net margin	-230.1%	Net Income: -2889940 Open source Revenue: 1255784 Open source
20212021-12-31	Net margin	-930%	Net Income: -5827507 Open source Revenue: 626619 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 126576 Open source Operating Cash Flow: -290983 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 479328 Open source Operating Cash Flow: -902486 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 62274 Open source Operating Cash Flow: -1231077 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 225293 Open source Operating Cash Flow: -726705 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 1790168 Open source Operating Cash Flow: -1018070 Open source
20182018-12-31	Free cash flow margin	-22%	Revenue: 3711327 Open source Operating Cash Flow: -234673 Open source Capital Expenditure: 581632 Open source
20192019-12-31	Free cash flow margin	-206.2%	Revenue: 2133624 Open source Operating Cash Flow: -2934441 Open source Capital Expenditure: 1464494 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 1255784 Open source Operating Cash Flow: -1284240 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 626619 Open source Operating Cash Flow: -487000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -487K 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Operating cash flow	-290983	Operating Cash Flow: -290983 Open source
20132013-12-31	Operating cash flow	-902486	Operating Cash Flow: -902486 Open source
20142014-12-31	Operating cash flow	-1231077	Operating Cash Flow: -1231077 Open source
20162016-12-31	Operating cash flow	-726705	Operating Cash Flow: -726705 Open source
20172017-12-31	Operating cash flow	-1018070	Operating Cash Flow: -1018070 Open source
20182018-12-31	Operating cash flow	-234673	Operating Cash Flow: -234673 Open source
20192019-12-31	Operating cash flow	-2934441	Operating Cash Flow: -2934441 Open source
20202020-12-31	Operating cash flow	-1284240	Operating Cash Flow: -1284240 Open source
20212021-12-31	Operating cash flow	-487000	Operating Cash Flow: -487000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.4M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -290983 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -902486 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1231077 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -726705 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1018070 Open source
20182018-12-31	Free cash flow	-816305	Operating Cash Flow: -234673 Open source Capital Expenditure: 581632 Open source
20192019-12-31	Free cash flow	-4398935	Operating Cash Flow: -2934441 Open source Capital Expenditure: 1464494 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1284240 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -487000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

114.7% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Liabilities / assets	Not reported	Total Assets: 248889 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 647529 Open source
20142014-12-31	Liabilities / assets	374.6%	Total Liabilities: 1295024 Open source Total Assets: 345695 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 452467 Open source
20172017-12-31	Liabilities / assets	30.8%	Total Liabilities: 293609 Open source Total Assets: 954132 Open source
20182018-12-31	Liabilities / assets	55.5%	Total Liabilities: 1015076 Open source Total Assets: 1830329 Open source
20192019-12-31	Liabilities / assets	64.4%	Total Liabilities: 2876574 Open source Total Assets: 4465691 Open source
20202020-12-31	Liabilities / assets	93.6%	Total Liabilities: 4405598 Open source Total Assets: 4706708 Open source
20212021-12-31	Liabilities / assets	114.7%	Total Liabilities: 5563655 Open source Total Assets: 4851125 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.12× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Current assets / current liabilities	0.4×	Current Assets: 168292 Open source Current Liabilities: 415993 Open source
20132013-12-31	Current assets / current liabilities	0.52×	Current Assets: 373247 Open source Current Liabilities: 718629 Open source
20142014-12-31	Current assets / current liabilities	0.07×	Current Assets: 96732 Open source Current Liabilities: 1295024 Open source
20162016-12-31	Current assets / current liabilities	1.74×	Current Assets: 258577 Open source Current Liabilities: 149013 Open source
20172017-12-31	Current assets / current liabilities	2.27×	Current Assets: 667602 Open source Current Liabilities: 293609 Open source
20182018-12-31	Current assets / current liabilities	0.87×	Current Assets: 869521 Open source Current Liabilities: 1000462 Open source
20192019-12-31	Current assets / current liabilities	0.28×	Current Assets: 604427 Open source Current Liabilities: 2186744 Open source
20202020-12-31	Current assets / current liabilities	0.19×	Current Assets: 722462 Open source Current Liabilities: 3784118 Open source
20212021-12-31	Current assets / current liabilities	0.12×	Current Assets: 518298 Open source Current Liabilities: 4476654 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	−USD 387,748 Exact value Exact value: -387748 USD 2012-01-01 – 2012-12-31: -387748 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2012-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -387748 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -387748 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116414000236/ntfl-20131231.xml#253389 Filing: 000151116414000236 The citation records this snapshot. The page link may show a newer release later.	−USD 290,983 Exact value Exact value: -290983 USD 2012-01-01 – 2012-12-31: -290983 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2012-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -290983 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -290983 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116414000236/ntfl-20131231.xml#12073 Filing: 000151116414000236 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 2.08 million Exact value Exact value: -2083359 USD 2013-01-01 – 2013-12-31: -2083359 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2013-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -2083359 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2083359 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116415000238/ntfl-20141231.xml#195314 Filing: 000151116415000238 The citation records this snapshot. The page link may show a newer release later.	−USD 902,486 Exact value Exact value: -902486 USD 2013-01-01 – 2013-12-31: -902486 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2013-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -902486 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -902486 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116415000238/ntfl-20141231.xml#14373 Filing: 000151116415000238 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 2.08 million Exact value Exact value: -2075720 USD 2014-01-01 – 2014-12-31: -2075720 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2014-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -2075720 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2075720 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116415000238/ntfl-20141231.xml#198950 Filing: 000151116415000238 The citation records this snapshot. The page link may show a newer release later.	−USD 1.23 million Exact value Exact value: -1231077 USD 2014-01-01 – 2014-12-31: -1231077 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2014-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -1231077 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1231077 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116415000238/ntfl-20141231.xml#14212 Filing: 000151116415000238 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 2.1 million Exact value Exact value: -2098771 USD 2016-01-01 – 2016-12-31: -2098771 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2016-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -2098771 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2098771 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116418000246/ntfl-20171231.xml#190842 Filing: 000151116418000246 The citation records this snapshot. The page link may show a newer release later.	−USD 726,705 Exact value Exact value: -726705 USD 2016-01-01 – 2016-12-31: -726705 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2016-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -726705 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -726705 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000151116418000246/ntfl-20171231.xml#183616 Filing: 000151116418000246 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 23.63 million Exact value Exact value: -23629117 USD 2017-01-01 – 2017-12-31: -23629117 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2017-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -23629117 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23629117 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000147793219001448/nlbs-20181231.xml#237040 Filing: 000147793219001448 The citation records this snapshot. The page link may show a newer release later.	−USD 1.02 million Exact value Exact value: -1018070 USD 2017-01-01 – 2017-12-31: -1018070 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2017-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -1018070 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1018070 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000147793219001448/nlbs-20181231.xml#233133 Filing: 000147793219001448 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 2.07 million Exact value Exact value: -2074537 USD 2018-01-01 – 2018-12-31: -2074537 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2018-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -2074537 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2074537 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221006466/nlbs-20191231.xml#84623 Filing: 000149315221006466 The citation records this snapshot. The page link may show a newer release later.	−USD 234,673 Exact value Exact value: -234673 USD 2018-01-01 – 2018-12-31: -234673 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2018-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -234673 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -234673 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221006466/nlbs-20191231.xml#294945 Filing: 000149315221006466 The citation records this snapshot. The page link may show a newer release later.	USD 581,632 Exact value Exact value: 581632 USD 2018-01-01 – 2018-12-31: 581632 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRALIFE BIOSCIENCES, INC · 2018-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Capital Expenditure: 581632 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 581632 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221006466/nlbs-20191231.xml#119293 Filing: 000149315221006466 The citation records this snapshot. The page link may show a newer release later.	−USD 816,305 Calculation and evidence -234673 − 581632 USD Exact free cash flow: -816305 USD 2018-01-01 – 2018-12-31: -234673 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 581632 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRALIFE BIOSCIENCES, INC · 2018-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Free cash flow: -816305 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -234673 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221006466/nlbs-20191231.xml#294945 Filing: 000149315221006466 Input fundies:CapitalExpenditure: 581632 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221006466/nlbs-20191231.xml#119293 Filing: 000149315221006466 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 4.01 million Exact value Exact value: -4007403 USD 2019-01-01 – 2019-12-31: -4007403 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2019-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -4007403 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4007403 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221015197/nlbs-20201231.xml#85623 Filing: 000149315221015197 The citation records this snapshot. The page link may show a newer release later.	−USD 2.93 million Exact value Exact value: -2934441 USD 2019-01-01 – 2019-12-31: -2934441 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2019-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -2934441 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2934441 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221015197/nlbs-20201231.xml#123227 Filing: 000149315221015197 The citation records this snapshot. The page link may show a newer release later.	USD 1.46 million Exact value Exact value: 1464494 USD 2019-01-01 – 2019-12-31: 1464494 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRALIFE BIOSCIENCES, INC · 2019-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Capital Expenditure: 1464494 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1464494 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221015197/nlbs-20201231.xml#127886 Filing: 000149315221015197 The citation records this snapshot. The page link may show a newer release later.	−USD 4.4 million Calculation and evidence -2934441 − 1464494 USD Exact free cash flow: -4398935 USD 2019-01-01 – 2019-12-31: -2934441 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1464494 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRALIFE BIOSCIENCES, INC · 2019-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Free cash flow: -4398935 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2934441 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221015197/nlbs-20201231.xml#123227 Filing: 000149315221015197 Input fundies:CapitalExpenditure: 1464494 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315221015197/nlbs-20201231.xml#127886 Filing: 000149315221015197 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 2.89 million Exact value Exact value: -2889940 USD 2020-01-01 – 2020-12-31: -2889940 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2020-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -2889940 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2889940 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#917482 Filing: 000149315222009623 The citation records this snapshot. The page link may show a newer release later.	−USD 1.28 million Exact value Exact value: -1284240 USD 2020-01-01 – 2020-12-31: -1284240 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2020-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -1284240 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1284240 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#936517 Filing: 000149315222009623 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 5.83 million Exact value Exact value: -5827507 USD 2021-01-01 – 2021-12-31: -5827507 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRALIFE BIOSCIENCES, INC · 2021-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Net Income: -5827507 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5827507 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#917120 Filing: 000149315222009623 The citation records this snapshot. The page link may show a newer release later.	−USD 487,000 Exact value Exact value: -487000 USD 2021-01-01 – 2021-12-31: -487000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRALIFE BIOSCIENCES, INC · 2021-12-31 NUTRALIFE BIOSCIENCES, INC (edgar:1563463) Operating Cash Flow: -487000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563463/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -487000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563463/000149315222009623/form10-k.htm#1030750 Filing: 000149315222009623 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 1,971 latest values · 1,971 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001563463, 1563463, edgar:1563463, nlbs, ntfl

Also known as NUTRAFUELS INC, NUTRALIFE BIOSCIENCES, INC, NUTRALIFE BIOSCIENCES, INC., NUTRALIFE BIOSCIENCES, INC, NUTRALIFE BIOSCIENCES, INC.

NUTRALIFE BIOSCIENCES, INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation